Bone marrow immunosuppressive states associate with survival after guadecitabine and atezolizumab therapy in HMA-R/R MDS. - Jang HJ; Urrutia G; Ørskov AD; Nguyen AV; Kim HJ; Nelson SA; Lee H; Burgos RS; Johnson BK; Wegener M; Becker K; Adams M; et al. (Blood neoplasia, 2026)